Buyback yield (TTM)
1.32%
Shareholder yield (TTM)
3.44%
5Y share count change
-9.0%
Buyback spend (TTM)
$7.85B
Cumulative buybacks
$129.04B
Key takeaways
- Johnson & Johnson (JNJ) repurchased about $7.85B of stock over the trailing twelve months.
- Diluted share count is down 9.0% over the last ~5 fiscal years — buybacks are net-shrinking the share base.
- TTM buyback ÷ stock-based-comp ratio of 5.75× — repurchases more than cover SBC dilution.
- Cash buyback spend has compounded at +13.1% per year over the latest 5-year window.
- TTM repurchases used about 149% of free cash flow remaining after dividends.
Dividend & buyback yield over time for Johnson & Johnson (JNJ)
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Diluted vs basic shares (annual) for Johnson & Johnson (JNJ)
Diluted weighted-average shares are the EPS denominator — a falling count means buybacks are outpacing SBC dilution.
Year-over-year change in diluted shares for Johnson & Johnson (JNJ)
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Cash buyback spend over time for Johnson & Johnson (JNJ)
Latest: $5.95B
Overview
As of the 2025 fiscal year, Johnson & Johnson (JNJ) reported buyback spend of $5.95B – surged 144.8% year-over-year.
Over 2020–2025 (5 years), Johnson & Johnson buyback spend expanded at a +13.1% compound annual rate, with mixed annual results across the window.
Between 2012 and 2025, Johnson & Johnson buyback spend plunged 53.9%, falling from $12.92B to $5.95B.
Across the available history, buyback spend reached its high of $12.92B in 2012 and its low of $153.00M in 1989.
Johnson & Johnson Buyback Spend 2025: $5.95B
2025's buyback spend for Johnson & Johnson came in at $5.95B, surged 144.8% from 2024.
Johnson & Johnson Buyback Spend 2024: $2.43B
Johnson & Johnson posted buyback spend of $2.43B in 2024, plunged 51.9% below 2023.
Johnson & Johnson Buyback Spend 2023: $5.05B
In 2023, Johnson & Johnson reported buyback spend of $5.05B, declined 16.3% below 2022.
Johnson & Johnson Buyback Spend 2022: $6.04B
Johnson & Johnson buyback spend in 2022 was $6.04B, surged 74.6% from 2021.
Johnson & Johnson Buyback Spend 2021: $3.46B
Johnson & Johnson buyback spend in 2021 was $3.46B.
See more financial history for Johnson & Johnson (JNJ).
Buyback, SBC & dilution history
Buyback spend, SBC, net dilution effect, and share count.
| 2025 | $5.95B | $1.35B | $4.60B | 1.18% | 2.43B | 0.0% | |
| 2024 | $2.43B | $1.18B | $1.26B | 0.70% | 2.43B | -5.1% | |
| 2023 | $5.05B | $1.16B | $3.89B | 1.34% | 2.56B | -3.9% | |
| 2022 | $6.04B | $1.14B | $4.90B | 1.31% | 2.66B | -0.4% | |
| 2021 | $3.46B | $1.14B | $2.32B | 0.77% | 2.67B | +0.1% | |
| 2020 | $3.22B | $1.00B | $2.22B | 0.78% | 2.67B | -0.5% | |
| 2019 | $6.75B | $977.00M | $5.77B | 1.76% | 2.68B | -1.6% | |
| 2018 | $5.87B | $978.00M | $4.89B | 1.67% | 2.73B | -0.6% | |
| 2017 | $6.36B | $962.00M | $5.40B | 1.69% | 2.75B | -1.6% | |
| 2016 | $8.98B | $878.00M | $8.10B | 2.88% | 2.79B | -0.9% | |
| 2015 | $5.29B | $874.00M | $4.42B | 1.87% | 2.81B | -1.8% | |
| 2014 | $7.12B | $792.00M | $6.33B | 2.45% | 2.86B | -0.5% | |
| 2013 | $3.54B | $728.00M | $2.81B | 1.37% | 2.88B | +2.3% | |
| 2012 | $12.92B | $662.00M | $12.26B | 6.63% | 2.81B | +1.3% | |
| 2011 | $2.52B | $621.00M | $1.90B | 1.41% | 2.78B | -0.5% | |
| 2010 | $2.80B | $614.00M | $2.18B | 1.65% | 2.79B | -0.0% | |
| 2009 | $2.13B | $628.00M | $1.50B | 1.20% | 2.79B | -1.6% | |
| 2008 | $6.65B | $627.00M | $6.02B | 4.01% | 2.84B | -2.6% | |
| 2007 | $5.61B | $698.00M | $4.91B | 2.94% | 2.91B | -1.8% | |
| 2006 | $6.72B | $0.00 | $6.72B | 3.50% | 2.96B | -1.3% | |
| 2005 | $1.72B | $0.00 | $1.72B | 0.96% | 3.00B | +0.6% | |
| 2004 | $1.38B | $0.00 | $1.38B | 0.74% | 2.99B | -5.0% | |
| 2003 | $1.18B | $0.00 | $1.18B | 0.77% | 3.14B | +2.9% | |
| 2002 | $6.54B | $0.00 | $6.54B | 4.09% | 3.05B | -0.9% | |
| 2001 | $2.57B | $0.00 | $2.57B | 1.43% | 3.08B | -0.6% | |
| 2000 | $973.00M | $0.00 | $973.00M | — | 3.10B | +0.8% | |
| 1999 | $840.00M | $0.00 | $840.00M | — | 3.07B | +8.5% | |
| 1998 | $930.00M | $0.00 | $930.00M | — | 2.83B | +3.4% | |
| 1997 | $628.00M | $0.00 | $628.00M | — | 2.74B | +0.5% | |
| 1996 | $412.00M | $0.00 | $412.00M | — | 2.73B | — | |
| 1995 | $322.00M | $0.00 | $322.00M | — | — | — | |
| 1994 | $185.00M | $0.00 | $185.00M | — | — | — | |
| 1993 | $632.00M | $0.00 | $632.00M | — | — | — | |
| 1992 | $740.00M | $0.00 | $740.00M | — | — | — | |
| 1991 | $222.00M | $0.00 | $222.00M | — | — | — | |
| 1990 | $209.00M | $0.00 | $209.00M | — | — | — | |
| 1989 | $153.00M | $0.00 | $153.00M | — | — | — |
- 2025$5.95B
- 2024$2.43B
- 2023$5.05B
- 2022$6.04B
- 2021$3.46B
- 2020$3.22B
- 2019$6.75B
- 2018$5.87B
- 2017$6.36B
- 2016$8.98B
- 2015$5.29B
- 2014$7.12B
- 2013$3.54B
- 2012$12.92B
- 2011$2.52B
- 2010$2.80B
- 2009$2.13B
- 2008$6.65B
- 2007$5.61B
- 2006$6.72B
- 2005$1.72B
- 2004$1.38B
- 2003$1.18B
- 2002$6.54B
- 2001$2.57B
- 2000$973.00M
- 1999$840.00M
- 1998$930.00M
- 1997$628.00M
- 1996$412.00M
- 1995$322.00M
- 1994$185.00M
- 1993$632.00M
- 1992$740.00M
- 1991$222.00M
- 1990$209.00M
- 1989$153.00M
Buybacks vs stock-based compensation for Johnson & Johnson (JNJ)
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 5.75×.
Buybacks vs dividends (share of cash returned) for Johnson & Johnson (JNJ)
How Johnson & Johnson splits cash returned to shareholders between dividends and buybacks.
Sector peers by buyback spend
Companies in the same sector as Johnson & Johnson, ranked by their latest buyback spend.
| $5.54B | |
| $5.08B | |
| $4.11B | |
| $3.00B | |
| $980.00M | |
| $216.35M | |
| $0.00 | |
| $0.00 |
- $5.54B
- $5.08B
- $4.11B
- $980.00M
- $216.35M
- $0.00
- $0.00
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $5.28B (TTM FCF − TTM dividends, clamped at zero).
Frequently asked questions
Data & methodology
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation